Immune response and rational development of vaccines and biomarkers

Published on August 20, 2013   57 min

Other Talks in the Series: Tuberculosis

0:00
Hello, my name is Stefan Kaufmann. I'm from the Max Planck Institute for Infection Biology in Berlin, Germany. I would like to discuss with you the immune response and rational development of vaccines and biomarkers in tuberculosis.
0:20
This is the agenda of my presentation. I will briefly say a few words about the global threat of tuberculosis, and then also a few words about vaccinology. This is followed by the first major part of my presentation. The immune response underlying tuberculosis, which is then followed by a discussion of current vaccine candidates in tuberculosis, and then the salient features of biomarkers in tuberculosis. I will end my presentation with a few words about the cost of research and the gain for tuberculosis.
1:01
This is a map, we all know it. It shows the size of a country according to its geographic size. Big countries are big, small countries are small. However, Worldmapper has also developed another way of showing the importance of different countries.
1:24
In this presentation, the size of a country is related to its proportional impact. For example, here you see big countries because there are many passenger cars, like in the US, Europe or in Japan. You also see how thin and slim Africa is and also the Asian continent. This is because there are only a few cars in these countries. The map looks quite different if you look at it
Hide

Immune response and rational development of vaccines and biomarkers

Embed in course/own notes